Skip to main content
ToolsForensic AnalysisGLAXOSMITHKLINE SOUTH AFRICA

GLAXOSMITHKLINE SOUTH AFRICA

Supplier Forensic Analysis · Scanned: 2026/07/25

Open this supplier in the workbench →

These findings identify statistical unusualness and named data patterns for review. They do not establish wrongdoing and require source verification.

CIPC screening
Clear
Compliance
N/A/100
Awards
3
Total Value
R 3,3B

Recent Awards

3 awards · Total: R 3 258 098 027,08

Showing 5 of 3
HP07-2026DAI: Supply and Delivery of Pharmaceutical Products: Drops, Aerosols and Inhaled Medicines to the Department of Health for the period 01 September 2026 to 31 August 2029
Health and Welfare Sector Education and Training Authority
Ref: HP07-2026DAI
R 123 068 159,20
22 Jun 2026
SUPPLY AND DELIVERY OF VACCINES USED IN THE EXPANDED PROGRAMME ON IMMUNISATION (EPI) TO THE DEPARTMENT OF HEALTH FOR THE PERIOD 01 JANUARY 2027 TO 31 DECEMBER 2029
Health and Welfare Sector Education and Training Authority
Ref: HP16-2027EPI
R 1 589 022 993,60
11 May 2026
HP16-2024EPI: SUPPLY AND DELIVERY OF VACCINES USED IN THE EXPANDED PROGRAMME ON IMMUNISATION (EPI) TO THE DEPARTMENT OF HEALTH FOR THE PERIOD 01 JANUARY 2024 TO 31 DECEMBER 2026 ERRATUM 1: PLEASE NOTE THAT THE SPECIAL REQUIREMENTS AND CONDITIONS OF CONTRACT (SRCC) AS PUBLISHED WITH THE BID PACK ON 22 JULY 2022 FOR TENDER HP16-2024EPI IS BEING REPLACED WITH THIS ERRATUM.
Health
Ref: HP16-2024EPI
R 1 546 006 874,28
30 Mar 2023

AI Analysis

Powered by Gemini

AI Forensic Analysis

Get AI-generated audit narratives with key findings and recommended actions.
Paid access from R499/mo

or upgrade to Pro Subscription

Procurement context

Competitive concentration, procurement-intelligence context, province health, and restricted-supplier status are available to forensic subscribers.

Unlock forensic context →
CIPC screening signalsClear

No contributing warning signals in the current evidence.

Unlock Full Analysis

Get access to all forensic flags, evidence details, and AI-generated audit narratives.

View Full Intelligence Report

Get complete award history, director network, and compliance analysis.

View Report →